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Background: Tissue samples should be fixed and permanently stabilized as soon as possible ex-vivo to avoid variations
in proteomic content. Tissues collected from studies involving infectious microorganisms, must face the additional
challenge of pathogen inactivation before downstream proteomic analysis can be safely performed. Heat fixation
using the Denator Stabilizor System (Gothenburg, Sweden) utilizes conductive heating, under a mild vacuum, to
rapidly eliminate enzymatic degradation in tissue samples. Although many studies have reported on the ability of
this method to stop proteolytic degradation and other sample changes immediately and permanently, pathogen
inactivation has not been studied.
Results: We examined the ability of the heat fixation workflow to inactivate bacterial and viral pathogens and the
suitability of this tissue for Matrix Assisted Laser Desorption Ionization mass spectrometry imaging (MALDI-MSI).
Mice were infected with viral or bacterial pathogens representing two strains of Venezuelan Equine Encephalitis
virus (VEEV) and two strains of Burkholderia. Additionally, a tissue mimetic model was employed using Escherichia,
Klebsiella and Acinetobacter isolates. Infected tissue samples harvested from each animal or mimetic model were
sectioned in half. One half was heat fixed and the other remained untreated. Lysates from each sample were
checked for organism viability by performing plaque (infectivity) assays or plating on nutrient agar for colony
forming unit (CFU) calculation. Untreated infected control tissue demonstrated the presence of each viable
pathogen by positive plaque or colony formation, whereas heat fixation resulted in complete inactivation of both
the viral and bacterial pathogens. MALDI-MSI images produced from heat fixed tissue were reflective of molecular
distributions within brain, spleen and lung tissue structures.
Conclusions: We conclude that heat fixation inactivates viral and bacterial pathogens and is compatible with
proteomic analysis by MALDI-MSI. This treatment will enable the use of infected tissue from studies performed in
bio-safety level 3 laboratories with VEEV and Burkholderia to be safely used for proteomic, small molecule drug
detection, and imaging mass spectrometry analysis.
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Many challenges must be overcome for successful
proteomic analysis in tissue samples. When sampling is
performed in a manner optimal for experimental repro-
ducibility and is a representative “snapshot” of the or-
ganisms living state, the highest sample quality for
experimental analysis is achieved. Endogenous proteo-
lytic activity begins immediately following disruption of
oxygen and nutrients, and can continue during storage and
sample processing [1]. Therefore, in order to obtain reliable
and consistent results, tissue samples should be fixed and
permanently stabilized as soon as possible ex-vivo to avoid
significant variations in proteomic content throughout the
experimental processes [2,3]. Tissue samples collected
from animal studies involving infectious microorganisms
must face an additional challenge of pathogen inactivation
before downstream proteomic analysis can be safely per-
formed in a routine laboratory environment (biosafety
level 2). Therefore, biosampling procedures for infectious
disease research must be carefully considered and opti-
mized for both experimental integrity and safety.
Fixation of tissues can be accomplished by chemical or
physical treatment. Physical methods include cryo-
preservation, heating, and micro-waving. The most com-
mon chemical fixation method is 10% neutral buffered
formalin. This method is ideal for preserving cellular
morphology and inactivates most pathogens, but pro-
duces extensive covalent crosslinking within proteins
creating a challenge for subsequent proteomic and mass
spectrometric analysis. These crosslinks can be partially
reversed using antigen retrieval methods, to achieve
maximum detection of proteins and peptides [4]. How-
ever, amino acids, carbohydrates, lipids, phosphates, pro-
teins and ions, such as Cl(−) and K(+), have been shown
to leach from tissue sections into the aqueous fixative
medium, further creating sources of variability in mo-
lecular content [5]. Alcohol based fixatives can also pre-
serve morphology and are more compatible with
proteomic analysis [6], but suffer from the same poten-
tial problem of analyte leaching.
The most common physical method of tissue stabilization
used in proteomic and mass spectrometry analysis is snap-
freezing and cryo-preservation. Although this method can
be performed very quickly after tissue harvest, enzymatic
activity and degradation will begin again once the sample is
thawed for processing or sectioning [7,8] and pathogens
present in the tissue remain viable. Heat or microwave-
irradiation-enhanced fixation was first demonstrated in
1970 [9] and can be performed to enhance and shorten the
times for chemical fixation or be used alone. Recently a
method of heat fixation utilizing a combination of heat and
mild vacuum was reported to be a superior method for
proteome stabilization in tissue when compared to snap-
freezing [10]. Heat stabilization using the commerciallyavailable Denator Stabilizor System is compatible with
major proteomic workflows and is beneficial in preserving
peptides, proteins and their modifications in tissue samples
[11-13]. In addition, heat stabilized tissues exhibit similar
intensity distribution for marker ions as that seen in frozen
tissue sections used for matrix assisted laser desorption
ionization MALDI-MSI [8]. Although many studies have
reported on the ability of this method to stop proteolytic
degradation and other sample changes immediately and
permanently, pathogen inactivation has not been studied.
MALDI-MSI is a powerful tool for the generation of
multidimensional spatial expression maps of biomole-
cules directly from a thin tissue section. Cells, tissue sec-
tions or even whole body slices from small animals are
deposited onto a conductive glass or metal plate and
covered with matrix (usually a UV-absorbing weak or-
ganic acid dissolved in a volatile solvent). The analytes
in the tissue are extracted by the solvent and co-
crystallize with the matrix compound, which then facili-
tates the transfer of energy of the MALDI laser allowing
for the desorption/ionization of the analyte molecules.
Mass spectra can then be acquired across the tissue at
defined geometrical coordinates resulting in ion intensity
maps or images depicting the relative level of each
detected analyte. MALDI ion sources are well suited to
this application since they enable the ionization of
diverse biomolecules, including peptides, proteins, oli-
gonucleotides, sugars, lipids, and small molecule drugs
when the appropriate matrix is employed [14-16].
Unlike traditional proteomic techniques where spatial in-
formation is lost due to extraction and purification,
MALDI-MSI allows for the simultaneous detection of
many analytes while maintaining their spatial distribution
within a histologically defined tissue section. MALDI-MSI
is generally a non-targeted approach and does not require
any labels or specific probes. This makes MALDI-MSI an
extremely useful biomarker discovery tool as it facilitates
the collection of multiplexed data on the specific localiza-
tion of molecular ions in tissue sections, and allows for the
measurement and mapping of variations of these ions dur-
ing development and disease progression or treatment.
Therefore MALDI-MSI is valuable tool for monitoring the
response to infection with highly pathogenic organisms for
the discovery of biomarkers and therapeutic targets. This
work describes the effectiveness of heat fixation using the
Denator instrument for the inactivation of bacteria and vi-




The workflows used to evaluate the ability of heat fix-
ation using the Denator Stabilizor T1 system to inacti-
vate viral and bacterial pathogens in tissue samples are
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an in-vivo infection model as well as a tissue mimetic
model. Infected tissue samples were sectioned in half and
heat fixed or left untreated, followed by pathogen viability
assays. We chose to begin our investigation using a
“custom” heat fixation method of 95°C for 30 seconds
in the T1 Stabilizor instrument with the upper heater
position at 90%. The temperature, heater position and
stabilization time are settings that can be adjusted when
selecting the “custom” method option. This custom set-
ting is based on the default fresh structure preserving
method of 90-95°C for 10–20 seconds for most tissues.
The structure preserving method evacuates the
stabilizer card of air before heating takes place (to re-
duce the risk of oxidation), but does not compress the
tissue with further vacuum. The time and temperature
were chosen as starting points based on basic heat- in-
activation data of bacteria and viruses in foods [17-19].
According to the manufacturer’s guidelines, the T1 Sta-
bilizor instrument is compatible with tissue sample sizes
up to 33 mm in diameter and 7 mm in height, and there
is no lower limit for sample size. To determine the exact
amount of energy required for complete heat fixation,
the instrument uses algorithms which combine the de-
tails of the physical state (fresh or frozen) and the sam-
ple size (measured automatically by lasers).
Inactivation of viral pathogens in infected tissues
To evaluate if the heat fixation protocol inactivates viral
pathogens from infected tissues, Venezuelan equine en-
cephalitis virus (VEEV), an enveloped single stranded posi-
tive RNA virus classified in the Alphavirus genus and
Togaviridae family was selected for testing. VEEV infectionuntreated
or frozen
Heat Fixation
95 C for 30s
Embed duplicate tissues 
in OCT, process for 
MALDI-MSI
Mice infected with 
VEE virus or
Burkholderia bacteria
Harvest target tissue 
brain, spleen, lung
Section tissue in half
Test tissue for viable pathogen:
Figure 1 Workflows of experimental design to determine the ability of heain mice begins with the lymphoid tissues, followed by
viremia and penetration into and infection of the central
nervous system [13]. In this study, BALB/c or C57BL/6
mice were infected (i.n. or s.c) with the vaccine or virulent
strain of VEEV. Spleen and brain tissues harvested from in-
fected mice were left untreated, or subjected to heat fix-
ation and then lysates were prepared to determine viremia.
As shown in Table 1, the presence of viable viral pathogen
VEEV, (TC83 vaccine strain and virulent Trinidad donkey
strain) was confirmed in the untreated mouse brain tissue
lysates by positive plaque assays on Vero-76 cells. Viral ti-
ters from the TC83 VEEV infected untreated brain tissue
lysates (100-120 mg) ranged from 2.5 × 104 to 5.5 × 104
pfu/ml. Higher titers were obtained from untreated brain
tissue harvested from mice infected with the virulent VEEV
strain, ranging from 9.9 × 107 to 4.2 × 108. Lysates derived
from the untreated spleen of mice infected with the virulent
strain of VEEV exhibited titers of 6.5 × 103-2.5 × 106, how-
ever, no virus was recovered from the spleen tissue lysates
derived from the TC83 infected mice. This is not surprising
since mice challenged with live attenuated vaccine strain
TC83, develop lower virus titers in the blood and brain and
do not exhibit the histo-pathological lesions that occur in
the spleen, lymph nodes, and brain tissue of mice infected
with the virulent strain [20]. Most importantly, the heat
fixed brain and spleen tissue samples produced no positive
plaques indicating that both strains of VEEV were com-
pletely inactivated by the treatment.
Inactivation of bacterial pathogens in infected tissues
To evaluate the ability of the heat fixation method to inacti-
vate bacterial pathogens, the Gram negative bacilli Burkhol-
deria thailandensis, an avirulent strain, and BurkholderiaInject with bacterial
suspension (1011 cfu)
E.coli, Klebsiella or Acinetobacter
Mimetic tissue model





Test tissue for viable pathogen
Incubate at 37°C for 1 hour
Section tissue
In half
t fixation to inactive viral and bacterial pathogens.
Table 1 Viable virus determination from untreated and heat fixed VEEV (vaccine strain and virulent strain) infected tissue
Pathogen Tissue Weight (mg) Treatment Dilution and plaque count Average titer
(pfu/ml)10−1 10−2 10−3 10−4 10−5 10−6
VEE (TC83) vaccine strain brain 100 none 100+ 21 3 0 0 0 2.5E + 04
120 none 100+ 30 8 0 0 0 5.5E + 04
140 HF 0 0 0 0 0 0 0.0E + 00
125 HF 0 0 0 0 0 0 0.0E + 00
spleen 47 none 0 0 0 0 0 0 0.0E + 00
52 none 0 0 0 0 0 0 0.0E + 00
55 HF 0 0 0 0 0 0 0.0E + 00
50 HF 0 0 0 0 0 0 0.0E + 00
VEE (Trinidad donkey) virulent strain brain 210 none TNTC TNTC TNTC TNTC TNTC 42 4.2E + 08
240 none TNTC TNTC TNTC TNTC 58 14 9.9E + 07
220 none TNTC TNTC TNTC TNTC TNTC 37 3.7E + 08
190 none TNTC TNTC TNTC TNTC TNTC 34 3.4E + 08
190 HF 0 0 0 0 0 0 0.0E + 00
180 HF 0 0 0 0 0 0 0.0E + 00
260 HF 0 0 0 0 0 0 0.0E + 00
210 HF 0 0 0 0 0 0 0.0E + 00
spleen 60 none TNTC TNTC 42 7 0 0 2.5E + 06
50 none 45 13 0 0 0 0 8.8E + 03
50 none 39 11 0 0 0 0 7.5E + 03
70 none 38 9 0 0 0 0 6.5E + 03
50 HF 0 0 0 0 0 0 0.0E + 00
60 HF 0 0 0 0 0 0 0.0E + 00
50 HF 0 0 0 0 0 0 0.0E + 00
70 HF 0 0 0 0 0 0 0.0E + 00
TNTC = too numerous to count, HF = Heat fixed.
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selected for study. The initial stage of infection in BALB/C
mice with both of these strains results in the localization of
the pathogen in the upper and lower sections of the respira-
tory tract and transportation of bacteria within alveolar
macrophages to regional lymph nodes [21]. Mice were in-
fected via the i.n. route with B. thailandensis or B. mallei
and after 4 days, spleen and lung tissues were harvested
and subjected to either no treatment or heat fixation. Tis-
sues lysates were prepared for a bacterial viability assay. As
shown in Table 2, lysates from the untreated lung tissue
harvested from mice infected with B. thailandensis or B.
mallei exhibited colony counts in excess of 105 CFU/ml,
indicating that both bacteria invaded the lungs of all in-
fected mice. Viable bacterial counts in the untreated
spleen of B. thailandensis infected mice ranged from
7.0-7.6 × 104 CFU/ml. Conversely, there were no viable
bacteria detected in heat-fixed lung or spleen tissue, indicat-
ing complete inactivation. Spleen tissue was not harvestedfrom the B. mallei infected mice due to the fact that bacter-
ial numbers are consistently higher in the lungs than in
other tissues when an aerosol or intranasal infection
method is used [21].
In an effort to limit the use of animals for this study, we
employed a tissue mimetic model to further investigate
the ability of heat fixation to inactivate Gram negative bac-
teria from 3 families (Enterobacteriaceae, Moraxellaceae,
and Burkholderiaceae), and 4 different genera: Escherichia
coli (3 strains), Klebsiella pneumoniae, Acinetobacter bau-
mannii and Burkholderia thailandensis. Whole kidneys
harvested from uninfected control animals were inocu-
lated with the bacterial isolates (one isolate for each kid-
ney) and incubated at 37°C for 1 hour. After incubation,
the kidneys were sectioned in half and one half was heat
fixed and the other half was left untreated. Lysates of each
tissue were made as previously described and viable bac-
terial counts were determined by plating serial dilutions
on Lysogeny broth (LB) agar. As shown in Table 3, viable
Table 2 Viable bacteria determination from untreated
and heat-fixed Burkholderia infected tissue
Pathogen Tissue Weight
(mg)
Treatment cfu for Average
cfu/ml10−1
B. thailandensis lung 40 none 1000+ >1 × 105
52 none 1000+ >1 × 105
40 none 1000+ >1 × 105
56 HF 0 0.00
48 HF 0 0.00
34 HF 0 0.00
spleen 61 none 70 7.0 × 104
64 none 71 7.1 × 104
71 none 76 7.6 × 104
57 HF 0 0.00
45 HF 0 0.00
65 HF 0 0.00
B. mallei lung ND none 1000+ >1 × 105
ND none 1000+ >1 × 105
ND none 1000+ >1 × 105
ND HF 0 0.00
ND HF 0 0.00
ND HF 0 0.00
HF = Heat fixed, ND=not determined.
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all the untreated kidney tissue (>103 CFU/ml). No viable
bacteria was detected in the kidney tissue which was heat
fixed at 95°C for 30 seconds, indicating complete inactiva-
tion of all bacterial isolates present in the tissue mimetic.Table 3 Bacterial viability determination from untreated
and heat-fixed kidney tissue obtained from a tissue
mimetic model
Bacterial isolate Treatment 1:10 1:100 1:1000 cfu/ml
E.coli Top10 none TNTC 1000+ 1000+ >103
E.coli pGSV3-GmR none TNTC 1000+ 1000+ >103
E.coli pAM17-KanR none TNTC 1000+ 1000+ >103
Klebsiella pneumoniae none TNTC 1000+ 1000+ >103
Burkholderia thailandiensis none TNTC 1000+ 1000+ >103
Acinetobacter baumani none TNTC 1000+ 1000+ >103
Control (no bacteria) none 0 0 0 0
E.coli Top10 heat fixed 0 0 0 0
E.coli pGSV3-GmR heat fixed 0 0 0 0
E.coli pAM17-KanR heat fixed 0 0 0 0
Klebsiella pneumoniae heat fixed 0 0 0 0
Burkholderia thailandiensis heat fixed 0 0 0 0
Acinetobacter baumani heat fixed 0 0 0 0
Control (no bacteria) heat fixed 0 0 0 0
TNTC = too numerous to count, HF = Heat fixed.Evaluation of heat fixed tissue for compatibility with
MALDI-MSI
To evaluate the tissues for gross morphology and
MALDI-MSI, duplicate samples were heat-fixed and pre-
pared for sectioning by embedding in OCT and freezing
at −80°C. One untreated brain tissue and one untreated
lung tissue were also embedded in OCT. Cryo-sectioning
was performed and 10 μm sections were placed on ITO
coated slides for MALDI-MSI. Serial sections were H&E
stained to evaluate tissue morphology after heat fixation
(95°C for 30 s). Upon gross examination, heat fixation
increased the rigidity of the tissue samples and the tissue
appeared darker and slightly reduced in overall size.
Additionally, the tissue was more prone to fracturing du-
ring cryo-sectioning as compared to snap-frozen tissue.
As seen in Figure 2, the overall tissue structures are intact,
but morphology changes were observed at the cellular
level. Heat-fixed tissue displayed morphological changes
similar to those observed in most snap-frozen sections.
The expansion of water in the tissue upon freezing causes
a consistent distortion, creating a “swiss cheese” effect.
Some of these holes may be attributed to ice crystal for-
mation, although the snap-frozen brain, embedded using
the same method of immersion in pre-chilled isopentane
bath cooled with dry ice, did not display these holes. It has
been proposed that these small holes may be caused by
the formation of steam pockets within the tissue during
the rapid heating process [8].
The preservation of distinct morphological structures in
the tissue is apparent in the MALDI-MSI images pro-
duced from heat fixed brain, spleen and lung tissue. As
seen in Figure 3A, heat fixed spleen tissue exhibited differ-
ential expression of a peak at m/z 8426 ± 46 localized to
the areas of periarteriolar lymphocyte sheath (PALS), and
heat fixed lung tissue displayed a peak at m/z 12167 ± 67
unique to the primary bronchus. The large holes seen in
the serial H&E sections are not visible in the MALDI-MSI
images of the lung and spleen. This is most likely due to
analyte diffusion into these areas during tissue washing or
matrix application. Brain tissue structure is also preserved
and displays ions with differential expression in 2 regions
of the midbrain (Figure 3B inset). This is an indication that
the changes to the fine structure observed in the H&E of
the heat fixed tissue did not affect our ability to detect dif-
ferential expression of peptides and proteins by MALDI-
MSI, producing images reflective of the underlying morph-
ology. In addition, as shown in Figure 3B, the spectral pro-
file of the heat fixed brain tissue exhibits increased intensity
for peaks above 12 kDa as compared to frozen spectra from
the same brain region. Conversely spectra from untreated
tissue displayed a larger number of low molecular weight
ions, consistent with protein degradation.
In order to evaluate the effects of heat fixation with
pathogen inactivation on smaller tissue analytes, MALDI
SF lung HF spleenHF lung SF brain HF brain
8x
20x
Figure 2 H&E stained sections of snap frozen (SF) and heat fixed (HF) mouse tissue showing morphological detail at 8x (top panels) and 20x
(bottom panels) magnification. Tissues were heat-fixed at 95°C for 30 seconds or untreated and prepared for sectioning by embedding in OCT.
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and heat fixed brain sections. For this analysis an effort
was made to section and image similar brain regions for
better comparison of brain structures and the molecules
detected. Horizontal sections of mouse brain where
made through regions of the cerebrum and cerebellum,
sprayed with DHB matrix and subjected to MALDI-MSI
in reflector negative ion mode. As shown in Figure 3C,
the average total spectra exported from the compiled
MALDI-MSI data set for heat fixed and snap frozen
mouse brain both display numerous peaks representing
lipid ions in the m/z 700–950 region. Based on previous
published analysis of lipids mapped to mouse brain, the
major classes of lipids visible in heat fixed and snap fro-
zen brain tissue are glycerophospholipids such as phos-
phatidylinositol (PI), phosphatidylethanolamine (PE) and
phosphatidylserine (PS), and phosphosphingolipids such
as sphingomyelin [22]. These lipid classes are frequently
observed in brain tissue via MALDI-MS in negative ion
mode [23,24]. MALDI-MSI ion images produced for two
ions at m/z 715.5 and m/z 885.6 show differential ex-
pression within different brain regions, but the pattern
of expression is almost identical in the heat fixed and
frozen brain sections. The ion at m/z 885.6 is present only
in the inferior and superior colliculus, and corresponds well
to the deprotonated form of phosphoinositol (38:4) which
has a mass of 886.56 and is frequently observed in MALDI-
MSI lipid analysis of mouse and rat brain tissue [23]. The
ion at m/z 715.5 is primarily located in the cerebral cortex
and has a similar mass to deprotonated PE-Cer/Sphingo-
myelin (C35:1 m/z 716.58). The similarity of the acquired
spectra and images produced from heat fixed and frozen
brain tissue indicates that the lipid profile is preserved after
the pathogen inactivation/heat fixation process.
Discussion
Proteomic analysis of tissue infected with bacterial or viral
pathogens poses a dual challenge since both microbial
inactivation and tissue stabilization must be considered.The use of fresh or frozen tissue samples is not an option
for studies involving BSL-3 or BSL-4 level pathogens. Al-
though formalin fixation of such tissues is performed, the
prolonged fixation protocols (14–30 days) often dictated
to ensure pathogen inactivation, render tissue virtually
unusable for proteomic analysis due to extensive protein
crosslinking. Heat-fixation using the Denator Stabilizor
T1 instrument has been successfully applied to many
proteomic workflows using tissue, including 2D electro-
phoresis [25], analysis of protein phosphorylation and
other post-translational modifcations [11,26], but the use
of heat fixation for microbial inactivation has not been
studied previously. Recent reports by Goodwin et al.
[8,27,28] have determined that heat fixation, using the
basic structure preserving protocol, is compatible with
MALDI-MSI, and produces protein profiles and ion im-
ages similar to, but more stable over time than fresh fro-
zen. Since our method of pathogen inactivation requires a
longer heat-fixation time, we sought to ensure that this
treatment did not impair tissue morphology and structure
to a degree that would preclude its use for MALDI-MSI.
Our data indicate that heat fixation at 95°C for 30 sec-
onds is adequate for the inactivation of a + ssRNA envel-
oped virus in infected tissue samples. Initially, we chose as
our guideline the temperatures and times used to inacti-
vate viruses and bacteria in animal meat (pork beef or
chicken) or shellfish [18,19,29,30]. Complete inactivation
of the Hepatitis A virus, (a non-enveloped + ssRNA virus)
in shellfish can be achieved by heat treatment at 90°C for
1.5 minutes [18]. In pilot experiments, we chose time
points of 30 sec.-1.5 min. at 95°C for heat fixation of
VEEV (TC83) infected tissue (data not shown). However,
since VEEV was successfully inactivated at 30s, we did not
perform the longer fixation times in subsequent studies.
It is often assumed that small non-enveloped viruses
are among the most stable viruses and that viral sensitiv-
ity to heat increases with size and the presence of a viral
envelope. However, a recent study measuring the ther-
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Figure 3 A. MALDI-MSI of heat fixed tissue after pathogen inactivation. Tissue sections (10 µm) were prepared for MALDI-MSI of proteins and
peptides by spraying with sinapinic acid. a) H&E stained spleen serial section and pseudocolored MALDI-MSI ion overlay showing the expression
pattern of m/z 8416 (green: located in areas of periarteriolar lymphocyte sheath), and m/z 14986 (red: surrounding tissue). b) H&E stained serial
lung tissue section and pseudocolored image overlay showing the expression pattern of m/z 12167 (red: located in the primary bronchus), and
m/z 13800 (green: surrounding tissue). All masses are reported with a mass window of 0.4%. B. Overlay of representative MALDI-MSI spectra (500
combined laser shots) obtained from corresponding regions of heat fixed (red trace) and snap frozen (black trace) mouse brain tissue. Arrows
indicate the ions mapped in the inset image. Inset- pseudocolored ion image (top) and H&E of an adjacent section (bottom) of a heat fixed
mouse brain section showing the distribution of m/z 14121 (red) and m/z 6688 (green) located in two regions of the midbrain. C. MALDI-MSI of
heat fixed and snap frozen mouse brain tissue for lipid detection. (a) Average total MALDI spectra in reflector negative ionization mode obtained
from heat fixed (HF) and snap frozen (SF) mouse brain display numerous peaks representing lipid ions in the m/z 700-950 region. (b-c) Scanned
images of H&E stained and matrix (DHB) sprayed serial sections (left 2 panels) and pseudocolored overlays of ion images (right panels) in heat
fixed (HF) (b) and snap frozen (SF) (c) mouse brain. Horizontal mouse brain sections showing the expression pattern of two lipid species: m/z
885.6 (green) in the inferior and superior colliculus and m/z 715.5 (red) in the cerebral cortex. Dashed lines indicate MALDI-MSI measurement
regions. All masses are reported with a mass window of 0.1%. IC- inferior colliculus, SC-superior colliculus, CC- cerebral cortex, Cb-cerebellum.
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ture and thermal stability [31]. This study reported
that most viruses were inactivated by heating to 73°C
for 3 minutes in a liquid matrix and that virus infectiv-
ity loss occurs much more rapidly than does loss of
amplifiable viral RNA or DNA. Indeed, Baert et al.
reported that RT-PCR determination for the presence
of mouse norovirus (MNV) did not correlate with the
infectivity of virus particles after heat treatment [32].
Therefore, the loss of virus infectivity observed after
heat treatment is most likely due to denaturation
of the capsid protein. Further studies are necessary to
determine the heat fixation parameters required for
the inactivation of viruses from non-enveloped and
“naked” virus types.
The method of heat fixation using the Denator T1 Stabi-
lizor was adequate for the inactivation of Gram negative
bacteria from 3 families (Enterobacteriaceae, Moraxella-
ceae, and Burkholderiaceae). It is likely that this treatment
will inactivate most other gram negative bacterial isolates.
Since the cell wall of Gram-negative organisms is much
more complex than the cell wall of Gram-positive bac-
teria, our heat fixation parameters may be adequate for in-
activation, with the exception of spores. Further studies
using tissue infected with Gram positive bacteria are ne-
cessary to ensure safe handling after heat fixation.
Our MALDI-MSI images are reflective of molecular
abundances and distributions within tissue structures in
heat fixed brain, spleen and lung tissue. By embedding
heat fixed tissue in OCT, cryo-sections can be obtained
although the tissue is prone to fracturing. To alleviate
this problem, fragile heat-fixed tissue has been cryo-
sectioned with the assistance of carbon conductive tape,
in preparation for MALDI-MSI [27]. The tissue morph-
ology we observed after heat fixation is of adequate in-
tegrity to obtain MALDI-MSI images and spectra of
good quality, however, changes to cellular fine structure
were observed. The source of these tissue changesand/or artifacts has not been determined. The protein/
peptide spectra produced from heat-fixed brain tissue
displays many common ions with spectra from fresh-
frozen tissue, although there were fewer low molecular
weight ions visible in the average spectra exported from
heat fixed brain tissue. Since a direct comparison of
heat-fixed to frozen tissue profiles was not the goal of
this study, an in-depth analysis of the spectral profiles
was not performed. However, this observation is con-
sistent with a recent study by Stingl et al., which re-
ported fewer ex-vivo formed peptides in rodent brain
tissue heat-fixed samples as compared to fresh frozen
material [3].
MALDI-MSI has been widely used to analyze a
variety of lipids in tissue sections [33-36]. Due to the
high content and diversity of lipids in the central
nervous system, brain tissue often serves as a model
for MALDI-MSI method development. We therefore
sought to determine the impact heat fixation had on
lipid detection within mouse brain sections using
MALDI-MSI. Brain tissue heat fixed for pathogen
inactivation produced a pattern of lipid expression
similar to snap frozen brain tissue indicating that the
treatment did not change the lipid analyte content or
distribution. Although there are no published studies
which directly compare the lipid content of heat fixed
and snap frozen tissues, recent studies have highlighted
the importance of careful pre-analytical sample hand-
ling of tissue for lipid analysis as many lipids are
unstable, prone to oxidation and breakdown by tissue
lipases [37,38]. In one such study, heat fixation of
brain tissue successfully prevented the post-sampling
breakdown of lipids and the release of free fatty acids
through heat inactivation of lipases [37]. In this
respect, heat fixation using the Denator T1 stabilizor is
a valuable tool for the preservation of the spatial distri-
bution of lipids in tissues providing a representative
“snapshot” of an organisms living state.
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Heat fixation of 95°C for 30 seconds using the Denator T1
Stabilizor can be used for the inactivation of ssRNA(+)
enveloped viruses and Gram negative bacteria and is com-
patible with MALDI-MSI for protein/peptide and lipid
analysis. To our knowledge this is the first report of the
ability of this treatment to inactivate microbes. Further
studies will be focused on the effectiveness of this treat-
ment for the inactivation of other pathogenic viruses and
bacteria. This tissue stabilization method is simple and
rapid, and will facilitate the use of infected tissue samples
from animal or human studies for downstream proteomic,
small molecule drug detection, and imaging mass spec-
trometry analysis.
Methods
Animal Experiments and tissue mimetic model
Female BALB/c or C57BL/6 mice obtained from Charles
River Laboratory (Frederick, MD) were infected intra-
nasally (i.n.) or sub-cutaneously (s.c) with the viral
pathogen Venezuelan equine encephalitis virus (VEEV),
or the bacterial pathogens, Burkholderia thailandensis
or Burkholderia mallei. Four mice total were infected
with the vaccine strain of VEEV (TC83, i.n., 106 pfu) or
the virulent strain (Trinidad donkey: s.c., 104 pfu). Four
mice were infected with B.thailandensis and 3 mice were
infected with B.mallei. (i.n., 105 CFU). Additional inacti-
vation studies were conducted using a tissue mimetic
model. Briefly, kidneys were harvested from uninfected
control animals used in the above studies and injected
with one of the following bacterial isolates: E.coli
(Top10, PGSV3-GmR pAM17-KanR), Klebsiella pneu-
monia, Acinetobacter baumani or Burkholderia thailan-
densis, ex-vivo using a 1 ml tuberculin syringe loaded
with a 100 μl suspension of 3 × 108 CFU/ml in PBS.
One kidney was used for each bacterial isolate and one
was used as an uninfected control.
Research was conducted under an IACUC approved
protocol in compliance with the Animal Welfare Act,
PHS Policy, and other Federal statutes and regulations
relating to animals and experiments involving animals.
The facility where this research was conducted is accre-
dited by the Association for Assessment and Accredit-
ation of Laboratory Animal Care, and adheres to
principles stated in the Guide for the Care and Use of
Laboratory Animals, National Research Council, 2011.
Heat fixation
After active infection was established (4–5 days), the pri-
mary target organs for each pathogen were harvested:
brain and spleen from VEEV- infected mice and lung
and spleen from Burkholderia- infected animals. Brain
and spleen were removed aseptically from each of the 4
mice infected with the vaccine strain of VEEV. Two ofthe tissue sets (brain and spleen) were quickly divided in
half. One half was heat fixed and the other half was left
untreated. These tissues were used for viral titer deter-
mination. The brain and spleen from the other two ani-
mals were heat fixed or snap frozen whole and were
used for MALDI-MSI studies (see below). All tissues re-
covered from the mice infected with the virulent strain
of VEEV were sectioned in half and used to make lysates
for viral titer determination.
Lung and spleen harvested from 4 mice infected with
B. thailandensis were also divided in half, with one half
heat fixed and the other untreated. Three paired tissue
sets (heat-fixed and untreated) were used for CFU deter-
mination and the last pair was processed for MALDI-
MSI. For the tissue mimetic samples, kidneys harvested
from mice were injected with one of six different bacter-
ial isolates and incubated at 37°C for 1 hour. The tissues
were divided in half. One half was heat fixed and the
other half was left untreated.
Heat fixation was performed using the T1 Stabilizor
(Denator, Gothenburg, Sweden). Briefly, tissues were
placed in the stabilizer card (Denator) according to the
manufacturer’s guidelines and the instrument was pro-
grammed to a “custom” setting of 95°C for 30 seconds
(based on the “fresh structure preserving” method) with
a heater position of 90%. The temperature, upper heater
position and stabilization time are settings that can be
adjusted when selecting the “custom” method option in
the instrument. Tissue weights ranged from 34-260 mg
before heat fixation.
Viable pathogen determination
Tissue samples were weighed and lysates made with a
Precellys®24-Dual (Bertin Technologies, Rockville, MD
USA) bead beater device in 500 μl of RPMI-1640 media
with 10% fetal bovine serum (FBS) for virus infected tis-
sue or water for bacterial infected tissue. For the deter-
mination of viable virus from brain and spleen tissue,
lysates were used in a plaque assay using Vero-76 cells.
Cells were plated in 6-well plates 24 to 48 hours prior to
use in assay, and plates were carried into the BSL-3 lab.
SeaKem ME Agarose (Lonza, Rockland, MD, USA) was
prepared for overlays by mixing an appropriate amount of
agarose with an appropriate amount of Basal Medium
Eagle (BME) to achieve the desired concentration (i.e., 1 g
of agarose mixed with 100 ml of BME to achieve 1% agar-
ose concentration). Agarose was melted by microwave in
BSL-3 prior to use. Samples were diluted in 1× MEM
(minimal essential media), supplemented with 10% FBS
(vol/vol), in a 10-fold dilution scheme according to the ex-
perimental design. The culture medium in the 6-well plate
was then removed by swift decanting and various dilutions
of the virus inocula were added to duplicate or replicate
wells in volumes of 100 μl. Inoculum fluid was distributed
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37°C with 5% CO for about 1 hour. Without removal of
the inoculum or washing the virus off of the monolayer, a
primary liquid overlay containing a 1:1 ratio of 2× BME
medium (supplemented with 10% FBS) equilibrated to
42°C and 1% melted agarose was overlaid in 2 ml aliquots
onto the inoculated monolayer and allowed to solidify.
Plates were incubated for approximately 24 hours and
stained with 2 ml of secondary overlay which consisted of
1:1 volume ratio of 2× BME media + 10% FBS: 1% agarose,
and the combined volumes were supplemented with 5%
neutral red. Plaques were counted and recorded 24 hours
post-staining.
For determination of viable bacteria, lysates from lung,
spleen and the kidney mimetic model were tested by
plating 100 μl of serial dilutions on LB or blood agar in
duplicate and incubating for 48 h at 37°C. Bacterial load
was calculated as an average of the countable colonies
seen in each dilution.
MALDI-MSI-tissue preparation and matrix application
Parallel tissue samples (heat-fixed and untreated) from
the mouse infection studies were embedded in OCT
(optimal cutting temperature cryo-compound), (Sakura
Finetek, Torrence, CA, USA) freezing medium, immersed
in a pre-chilled isopentane bath cooled with dry ice to
freeze, and then stored frozen at −80°C. Sections (10 μm)
were made with a Leica cryostat (Leica CM1900 Leica
Microsystems Inc. Buffalo Grove, IL, USA) and were
placed on ITO coated slides (Bruker Daltonics, Billerica,
MA, USA) for MALDI-MSI. Serial sections (5 μm) were
hematoxylin and eosin (H&E) stained for morphological
analysis. After sectioning, the MALDI-MSI slides were
rinsed in 70% ethanol for 30 seconds, followed by 95%
ethanol for 30 seconds and a brief water wash to remove
the OCT compound. Finally, the slides were again rinsed
in 70% ethanol and 95% ethanol to dehydrate the tissue.
After 1 hour in a dessicator, slides were sprayed with sina-
pinic acid (SA: 10 mg/ml in 50% acetonitrile, 1% TFA) for
protein detection or 2,5-dihydroxybenzoic acid (DHB: 30
mg/ml in 50% methanol, 1% TFA) for lipid detection, in
an ImagePrep spraying device (Bruker Daltonics) using
the manufacturer’s recommended method for SA or DHB
application respectively. After matrix application, the
slides were stored in a dessicator under vacuum for 1 hour
before MALDI-MSI.
MALDI-MSI-instrument settings and data visualization
MALDI-MSI was performed on an AutoFlex III (Bruker
Daltonics) equipped with a SmartBeam™ laser (Nd: YAG,
355 nm). For protein detection the instrument was oper-
ated in linear positive–ion mode over a mass range of 2-20
kDa, with a raster width of 100 μm and a laser focal laser
spot size of 20 μm. Five hundred laser shots were summedat each location in a random walk pattern that collects 100
shot increments at five random areas within each location.
The extraction voltage was 19.94 kV, the acceleration volt-
age was 18.64 kV, and the lens voltage was 6.98 kV. Calibra-
tion was performed externally using protein standard mix
1(Bruker Daltonics). For lipid detection, the instrument was
operated in reflector mode with negative polarity over a
mass range of 100–1800 Da with a raster width of 100 μm
and 20 μm laser spot size, summing 500 shots at each loca-
tion with an acceleration potential of 20.97 kV. Spectra
were calibrated internally using the DHB matrix peaks of
m/z 153.02: [M-H]−, and m/z 307.04: [2M-H]−. All MALDI
mass spectrometry data was processed and images were
viewed using Flex Imaging 4.0 (Bruker Daltonics). Peaks
were selected with a mass window 0.4% for proteins and
0.1% for lipids and minimum intensity of 1%. All data was
normalized to total ion current.
Abbreviations
MALDI-MSI: Matrix assisted laser desorption ionization mass spectrometry
imaging; VEEV: Venezuelan equine encephalitis virus; PFU: Plaque forming
unit; CFU: Colony forming unit; OCT: Optimum cutting temperature;
ITO: Indium tin oxide; BSL-3,4: Biosafety laboratory level 3 or 4.
Competing interests
The authors declare that they have no competing interests.
Author’s contributions
LHC conceived of the study, coordinated the efforts, participated in all the
BLS-2 work, performed the MALDI-MSI and wrote the draft of the manuscript,
SVT participated in the VEEV (vaccine strain), and B.thailandensis mouse work,
JC performed the TC83 tissue processing and plaque assay, TK participated in
the work using B. thailandensis, and edited the draft, NLG and GD performed
the VEEV (virulent strain) study in BSL-3. DL performed the B.mallei BSL-3 study,
RGP contributed to study design and helped to draft the manuscript draft, SB
contributed to study design and coordinated the research efforts. All authors
have read and approved the manuscript.
Acknowledgements
This research was funded by JSTO under USAMRIID project number 1323839.
Opinions, interpretations, conclusions and recommendations are those of the
authors and are not necessarily endorsed by the US Army. This work was
sponsored by the U.S. Army Medical Research and Materiel Command. The
U.S. Army Medical Research Acquisition Activity (Fort Detrick, MD) is the
awarding and administering acquisition office. This document was prepared
as an account of work sponsored by an agency of the U.S. Government.
Neither the U.S. Government nor any of their employees makes any
warranty, expressed or implied, or assumes any legal liability or responsibility
for the accuracy, completeness, or usefulness of any information, apparatus,
product, or process disclosed or represents that its use would not infringe
privately owned rights. Reference herein to any specific commercial product,
process, or service by trade name, trademark, manufacturer, or otherwise
does not necessarily constitute or imply its endorsement, recommendation,
or favoring by the U.S. Government The views and opinions of authors
expressed herein do not necessarily state or reflect those of the U.S.
Government and shall not be used for advertising or product endorsement
purposes.
Author details
1Henry M. Jackson Foundation, Maryland, USA. 2DoD Biotechnology High
Performance Computing Software Applications Institute (BHSAI/TATRC),
Frederick, Maryland, USA. 3Division of Molecular and Translational Sciences,
US Army Medical Research Institute for Infectious Diseases (USAMRIID) Fort
Detrick, Maryland, USA.
Cazares et al. BMC Microbiology  (2015) 15:101 Page 11 of 11Received: 11 August 2014 Accepted: 23 April 2015
References
1. Sköld K, Alm H, Scholz B. The impact of biosampling procedures on
molecular data interpretation. Molecular & cellular proteomics : MCP.
2013;12(6):1489–501.
2. Jones RJ, Boyce T, Fennell M, Jacobs V, Pinto F, Duffield E, et al. The impact
of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in
human breast and bladder cancers. Cancer Chemother Pharmacol.
2008;61(1):23–32.
3. Stingl C, Söderquist M, Karlsson O, Borén M, Luider TM. Uncovering effects
of ex-vivo protease activity during proteomics and peptidomics sample
extraction in rat brain tissue by oxygen-18 labelling. J Proteome Res.
2014;13(6):2807–17.
4. Ronci M, Bonanno E, Colantoni A, Pieroni L, Di Ilio C, Spagnoli LG, et al.
Protein unlocking procedures of formalin-fixed paraffin-embedded tissues:
application to MALDI-TOF imaging MS investigations. Proteomics.
2008;8(18):3702–14.
5. Hackett MJ, McQuillan JA, El-Assaad F, Aitken JB, Levina A, Cohen DD, et al.
Chemical alterations to murine brain tissue induced by formalin fixation:
implications for biospectroscopic imaging and mapping studies of disease
pathogenesis. Analyst. 2011;136(14):2941–52.
6. Chaurand P, Latham JC, Lane KB, Mobley JA, Polosukhin VV, Wirth PS, et al.
Imaging mass spectrometry of intact proteins from alcohol-preserved tissue
specimens: bypassing formalin fixation. J Proteome Res. 2008;7(8):3543–55.
7. Goodwin RJ, Dungworth JC, Cobb SR, Pitt AR. Time-dependent evolution of
tissue markers by MALDI-MS imaging. Proteomics. 2008;8(18):3801–8.
8. Goodwin RJ, Lang AM, Allingham H, Borén M, Pitt AR. Stopping the clock
on proteomic degradation by heat treatment at the point of tissue excision.
Proteomics. 2010;10(9):1751–61.
9. Mayers CP. Histological fixation by microwave heating. J Clin Pathol.
1970;23(3):273–5.
10. Svensson M, Borén M, Sköld K, Fälth M, Sjögren B, Andersson M, et al.
Heat stabilization of the tissue proteome: a new technology for improved
proteomics. J Proteome Res. 2009;8(2):974–81.
11. Ahmed MM, Gardiner KJ. Preserving protein profiles in tissue samples:
differing outcomes with and without heat stabilization. J Neurosci Methods.
2011;196(1):99–106.
12. Kultima K, Sköld K, Borén M. Biomarkers of disease and post-mortem
changes - Heat stabilization, a necessary tool for measurement of protein
regulation. J Proteomics. 2011;75(1):145–59.
13. Sturm RM, Greer T, Woodards N, Gemperline E, Li L. Mass spectrometric
evaluation of neuropeptidomic profiles upon heat stabilization treatment of
neuroendocrine tissues in crustaceans. J Proteome Res. 2013;12(2):743–52.
14. Vestal ML. Modern MALDI time-of-flight mass spectrometry. Journal of mass
spectrometry : JMS. 2009;44(3):303–17.
15. Chaurand P, Schriver KE, Caprioli RM. Instrument design and
characterization for high resolution MALDI-MS imaging of tissue sections.
Journal of mass spectrometry : JMS. 2007;42(4):476–89.
16. Rohner TC, Staab D, Stoeckli M. MALDI mass spectrometric imaging of
biological tissue sections. Mech Ageing Dev. 2005;126(1):177–85.
17. Croci L, Ciccozzi M, De Medici D, Di Pasquale S, Fiore A, Mele A, et al.
Inactivation of hepatitis A virus in heat-treated mussels. J Appl Microbiol.
1999;87(6):884–8.
18. Sow H, Desbiens M, Morales-Rayas R, Ngazoa SE, Jean J. Heat inactivation of
hepatitis A virus and a norovirus surrogate in soft-shell clams (Mya arenaria).
Foodborne Pathog Dis. 2011;8(3):387–93.
19. Aguirre JS, Pin C, Rodriguez MR, Garcia de Fernando GD. Analysis of the
variability in the number of viable bacteria after mild heat treatment of
food. Appl Environ Microbiol. 2009;75(22):6992–7.
20. Kinney RM, Chang GJ, Tsuchiya KR, Sneider JM, Roehrig JT, Woodward TM,
et al. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is
encoded by the 5’-noncoding region and the E2 envelope glycoprotein.
J Virol. 1993;67(3):1269–77.
21. Lever MS, Nelson M, Ireland PI, Stagg AJ, Beedham RJ, Hall GA, et al.
Experimental aerogenic Burkholderia mallei (glanders) infection in the
BALB/c mouse. J Med Microbiol. 2003;52(Pt 12):1109–15.
22. Jackson SN, Wang HY, Woods AS. In situ structural characterization of
glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS.
J Am Soc Mass Spectrom. 2007;18(1):17–26.23. Sparvero LJ, Amoscato AA, Dixon CE, Long JB, Kochanek PM, Pitt BR, et al.
Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and
expectations. Chem Phys Lipids. 2012;165(5):545–62.
24. Jackson SN, Barbacci D, Egan T, Lewis EK, Schultz JA, Woods AS.
MALDI-Ion Mobility Mass Spectrometry of Lipids in Negative Ion
Mode. Analytical methods : advancing methods and applications.
2014;6(14):5001–7.
25. Scholz B, Sköld K, Kultima K, Fernandez C, Waldemarson S, Savitski MM,
et al. Impact of temperature dependent sampling procedures in
proteomics and peptidomics–a characterization of the liver and pancreas
post mortem degradome. Molecular & cellular proteomics: MCP.
2011;10(3):M900229-MCP900200-900221.
26. Rountree CB, Van Kirk CA, You H, Ding W, Dang H, VanGuilder HD, et al.
Clinical application for the preservation of phospho-proteins through
in-situ tissue stabilization. Proteome Sci. 2010;8:61.
27. Goodwin RJ, Nilsson A, Borg D, Langridge-Smith PR, Harrison DJ, Mackay CL,
et al. Conductive carbon tape used for support and mounting of both
whole animal and fragile heat-treated tissue sections for MALDI MS imaging
and quantitation. J Proteomics. 2012;75(16):4912–20.
28. Goodwin RJ, Pennington SR, Pitt AR. Protein and peptides in pictures:
imaging with MALDI mass spectrometry. Proteomics. 2008;8(18):3785–800.
29. Clavero MR, Beuchat LR, Doyle MP. Thermal inactivation of Escherichia coli
O157:H7 isolated from ground beef and bovine feces, and suitability of
media for enumeration. J Food Prot. 1998;61(3):285–9.
30. Thomas C, Swayne DE. Thermal inactivation of H5N1 high pathogenicity
avian influenza virus in naturally infected chicken meat. J Food Prot.
2007;70(3):674–80.
31. Tuladhar E, Bouwknegt M, Zwietering MH, Koopmans M, Duizer E. Thermal
stability of structurally different viruses with proven or potential relevance
to food safety. J Appl Microbiol. 2012;112(5):1050–7.
32. Baert L, Wobus CE, Van Coillie E, Thackray LB, Debevere J, Uyttendaele M.
Detection of murine norovirus 1 by using plaque assay, transfection assay,
and real-time reverse transcription-PCR before and after heat exposure.
Appl Environ Microbiol. 2008;74(2):543–6.
33. Anderson DM, Ablonczy Z, Koutalos Y, Spraggins J, Crouch RK, Caprioli RM,
et al. High resolution MALDI imaging mass spectrometry of retinal tissue
lipids. J Am Soc Mass Spectrom. 2014;25(8):1394–403.
34. Jones EE, Powers TW, Neely BA, Cazares LH, Troyer DA, Parker AS, et al.
MALDI imaging mass spectrometry profiling of proteins and lipids in clear
cell renal cell carcinoma. Proteomics. 2014;14(7–8):924–35.
35. Gode D, Volmer DA. Lipid imaging by mass spectrometry - a review.
Analyst. 2013;138(5):1289–315.
36. Guo S, Qiu L, Wang Y, Qin X, Liu H, He M, et al. Tissue imaging and serum
lipidomic profiling for screening potential biomarkers of thyroid tumors by
matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron
resonance mass spectrometry. Anal Bioanal Chem. 2014;406(18):4357–70.
37. Jerneren F, Söderquist M, Karlsson O. Post-sampling release of free fatty
acids - effects of heat stabilization and methods of euthanasia.
J Pharmacol Toxicol Methods. 2014;71C:13–20.
38. Patterson NH, Thomas A, Chaurand P. Monitoring time-dependent
degradation of phospholipids in sectioned tissues by MALDI imaging mass
spectrometry. Journal of mass spectrometry : JMS. 2014;49(7):622–7.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
